Document is current
Any future updates will be listed below
-
Authors
Stenmark Tullberg, Axel
Woxlin, Sara
Sjölin, Filippa
Ittner, Ella
Kovàcs, Anikò
Helou, Khalil
Holmberg, Erik
Karlsson, Per
-
Funding
Funding for this research was provided by:
The Swedish Cancer Society (21 1899 S & 22 2007 Pj)
The Swedish Research Council (2021-01388)
Stiftelsen Jubileumsklinikens Forskningsfond mot Cancer (2021:351)
LUA/ALF agreement (ALFGBG-965020 & ALFGBG-1005564)
- License Information
-
More Information
Article History
Received: 14 March 2025
Accepted: 27 June 2025
First Online: 23 July 2025
Competing interests
: The authors declare no competing non-financial interests but the following competing financial interests: Per Karlsson: Consulting or advisory role for Roche. Contract with PFS Genomics regarding genomic profiling. Co-inventor on patent applications. Contract with Prelude Dx. Erik Holmberg: Contract with PFS Genomics regarding genomic profiling. Co-inventor on patent applications. Contract with Prelude Dx. Axel Stenmark Tullberg; Co-inventor on patent applications. Contract with Prelude Dx.
